Skip to content

Stereotaxis STXS Net Income

Net Income at other companies

Abbott logo
AbbottABT
$1.08B-18.7%
Boston Scientific logo
Boston ScientificBSX
$1.34B+99.3%
Medtronic logo
MedtronicMDT
$1.24B+17.8%
Stryker logo
StrykerSYK
$745M+13.9%
ITG
Integer HoldingsITGR
$16.51M+173%
Merit Medical Systems logo
Merit Medical SystemsMMSI
$41M+36.0%

Other financials

Income statement

See full
Revenue$6.3M-15.8%
Gross profit$3.8M-6.6%
Operating income-$6.0M-0.9%
EPS (diluted)-$0.06+14.3%

Balance sheet

See full
Cash & equivalents$14.6M+36.7%
Total debt$5.3M-10.0%
Total equity$14.4M+399%
Total assets$54.0M+18.2%

Cash flow

See full
Operating cash flow-$3.4M-93.5%
CapEx$79.0K
Free cash flow-$3.5M

Valuation

See full
Market cap$168.11M-11.6%
Enterprise value$158.77M-15.9%
P/S5.4×-0.6×

Profitability

See full
Gross margin53.9%+0.5pp
Operating margin-71%-14.0pp
Net margin-69.5%-13.7pp
FCF margin-35.5%-2.4pp

Returns & leverage

See full
Return on equity-251.5%-29.9pp
Debt / equity0.4×-1.7×
Current ratio1.6×+0.5×

Where this comes from

Reported directly by Stereotaxis in its filing.

Tagged under the XBRL concept us-gaap:NetIncomeLoss.

The official record: Stereotaxis’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Stereotaxis's net income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Stereotaxis's net income?
Stereotaxis (STXS) reported net income of -$5.86M in Q1 2026.
How has Stereotaxis's net income changed year-over-year?
Stereotaxis's net income decreased by 0.7% year-over-year, from -$5.82M to -$5.86M.
What is the long-term trend for Stereotaxis's net income?
Over 4 years (2021 to 2025), Stereotaxis's net income has grown at a 19.2% compound annual growth rate (CAGR), from -$10.72M to -$21.64M.
What does net income mean?
The bottom line — total revenue minus all expenses, taxes, and costs. Represents the profit attributable to the company's shareholders after all obligations are met.